28 juillet 2022
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3390/v14081666
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36016289
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1999-4915
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Projects/314730_188877///
Ce document est lié à :
info:eu-repo/grantAgreement/FOUNDATION_NOVARTIS//21C149///
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_169EFDDEF7AA2
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
B. Mersinoglu et al., « The Impact of Epitranscriptomics on Antiviral Innate Immunity. », Serveur académique Lausannois, ID : 10.3390/v14081666
Epitranscriptomics, i.e., chemical modifications of RNA molecules, has proven to be a new layer of modulation and regulation of protein expression, asking for the revisiting of some aspects of cellular biology. At the virological level, epitranscriptomics can thus directly impact the viral life cycle itself, acting on viral or cellular proteins promoting replication, or impacting the innate antiviral response of the host cell, the latter being the focus of the present review.